About AIGen Therapeutics
AIGen Therapeutics is a company based in Gurugram (India) founded in 2019. It operates as a B2B. AIGen Therapeutics offers products and services including AI Platform and Proprietary Datasets. AIGen Therapeutics operates in a competitive market with competitors including BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others.
- Headquarter Gurugram, India
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Aigen Therapeutics Private Limited
- Date of Incorporation 08 May, 2019
- Jurisdiction Gurgaon, Haryana, India
-
Annual Revenue
Not available
-
Net Profit
-$5.05 K (USD)30.17as on Mar 31, 2022
-
EBITDA
-$4.94 K (USD)30.64as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AIGen Therapeutics
AIGen Therapeutics offers a comprehensive portfolio of products and services, including AI Platform and Proprietary Datasets.
AI system for designing therapies using data analytics and algorithms.
Platform analyzing genomics and proteomics for therapeutic discoveries.
Funding Insights of AIGen Therapeutics
Detailed funding history for AIGen Therapeutics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AIGen Therapeutics
Investment portfolio details for AIGen Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AIGen Therapeutics
Detailed financials for AIGen Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aigen Therapeutics Comparisons
Peer comparison for AIGen Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AIGen Therapeutics
AIGen Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| Locked | Locked | Locked |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| Locked | Locked | Locked |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| Locked | Locked | Locked |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| Locked | Locked | Locked |
Therapeutics for rare and ultra-rare metabolic diseases are developed.
|
Detailed competitors of AIGen Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aigen Therapeutics
Complete news archive for AIGen Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AIGen Therapeutics
AIGen Therapeutics was founded in 2019.
AIGen Therapeutics is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.
AIGen Therapeutics leverages proprietary AI algorithms and experimental datasets to create first-in-class therapies for deadly genetic and infectious diseases. The company combines AI with wet lab RD expertise to design biologics, antibodies, and peptides. It fosters clinical partnerships and analyzes vast datasets in genomics and proteomics for drug discovery. As a full-stack biotechnology startup, it focuses on innovative medicines through data analytics and supercomputing.
AIGen Therapeutics's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
AIGen Therapeutics offers AI Platform and Proprietary Datasets.